In recent years, infections caused by "drug-resistant" bacteria, which are difficult to treat, have been on the rise and have become a worldwide problem. People use antimicrobial agents for treatment, but bacterial cells become resistant and the drugs gradually become ineffective. The purpose of our research is to understand bacterial drug resistance mechanisms and to develop novel therapeutic strategies to overcome the problem of drug-resistant bacterial infections. In particular, we focus on the "drug efflux pumps" that allow bacteria to export drugs. We have identified many pump genes, found that they are involved in resistance, and that bacteria regulate the expression of these genes by sensing their environment. We are currently exploring the possibility of novel therapies to reduce drug resistance with the aim of developing drugs that inhibit these pumps. We are also working on the development of a new method to identify drug-resistant bacteria for early diagnosis and appropriate selection of antimicrobial agents. Our goal is to create a world without the burden of disease caused by infectious diseases.
Staff
2015 – present |
Professor, SANKEN, Osaka University (Distinguished Professor of Osaka University from 2020) |
2009 - 2015 |
Associate Professor, Institute of Scientific and Industrial Research, Osaka University |
2007 - 2009 |
Assistant Professor, Institute of Scientific and Industrial Research, Osaka University |
2006 – 2010 |
Researcher (concurrent) , PRESTO, Japan Science and Technology Agency |
2005 - 2007 |
Research Assistant Professor, Institute of Scientific and Industrial Research, Osaka University |
2003 - 2005 |
Post-doctoral Fellow |
2001 - 2003 |
Doctoral Fellow |
Current Research Topics
- Mechanisms of bacterial drug resistance
- Functional analysis of drug efflux pumps and development of inhibitors
- Development of a new methods to identify drug-resistant bacteria
- Physiological functions of efflux transporters and drug discovery